Minims Tetracaine Chlorhydrate Bausch + Lomb Ireland Limited (Tetracaine Hydrochloride)

Tetracaine Hydrochloride, the active ingredient in Minims Tetracaine Chlorhydrate Bausch + Lomb Ireland Limited, is a local anesthetic presented as an ophthalmic solution for ocular use. It produces rapid, reversible surface anesthesia, facilitating diagnostic eye examinations, foreign‑body removal, laser procedures and pre‑operative preparation in patients of all ages.

GNH USA supplies Minims Tetracaine Chlorhydrate Bausch + Lomb Ireland Limited as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance for ophthalmic care.

Tetracaine Hydrochloride is a topical ocular anesthetic used to numb the surface of the eye.

- Diagnostic ocular examinations: provides temporary anesthesia to allow thorough assessment without patient discomfort. - Minor eye procedures: facilitates foreign‑body removal, laser treatment and other minor interventions by numbing the ocular surface. - Pre‑operative ocular surgery: delivers pre‑operative anesthesia to prepare the eye for surgical procedures.

Tetracaine Hydrochloride may cause a range of ocular reactions.

Common Side Effects: - Stinging or burning sensation at the application site. - Transient itching or irritation. - Conjunctival hyperemia (redness). - Excessive tearing. - Blurred vision lasting a few minutes. - Mild corneal epithelial irritation.

Serious or Rare Side Effects: - Corneal epithelial toxicity or ulceration. - Severe allergic reaction (e.g., angio‑edema, anaphylaxis). - Persistent ocular inflammation. - Vision loss (rare). - Secondary infection due to compromised corneal integrity.

When using Tetracaine Hydrochloride, consider the following precautions.

- Allergy assessment: verify no known hypersensitivity to ester‑type local anesthetics. - Professional supervision: administer only under the direction of qualified eye‑care personnel. - Corneal integrity: avoid use on eyes with existing epithelial defects or infections. - Frequency limitation: do not exceed the recommended number of applications within a 24‑hour period. - Systemic absorption: monitor patients with extensive ocular surface exposure for systemic effects. - Store at room temperature: keep in the original container, protect from light and moisture.

Tetracaine Hydrochloride can interact with other ocular agents.

Major Interactions (Avoid): - Concurrent use of other topical ocular anesthetics: increased risk of cumulative corneal toxicity. - Contact lens wear during treatment: may enhance drug absorption and cause irritation.

Moderate Interactions (Monitor Closely): - Anticholinergic eye drops: possible alteration of pupil response. - Beta‑blocker ophthalmic solutions: monitor intra‑ocular pressure changes. - Systemic antiarrhythmic drugs: theoretical additive sodium‑channel blockade. - Topical corticosteroids: may mask early signs of corneal toxicity.